HER-2 is an epidermal growth factor receptor involved in the recruitment of various proteins, which in turn leads to activation of signal transduction cascades including PI3K/AKT/mTOR and RAF-MEK-ERK pathways, providing a pro-survival environment in breast cancer cells leading to chemotherapy resistance. The gene discussed is ERBB2; the disease is breast cancer.